Cartalax (AED peptide) record · updated 6h ago
Cartalax (AED) is a synthetic Khavinson tripeptide researched as a cartilage and connective tissue bioregulator, with most evidence drawn from Russian preclinical and gerontology work.
Development stage
where Cartalax (AED peptide) sits between preclinical work and regulatory approval- 1CurrentPreclinicalAnimal / in-vitro work
- 2Not reachedPhase 1Safety in humans
- 3Not reachedPhase 2Efficacy signal
- 4Not reachedPhase 3Confirmatory trials
- 5Not reachedApprovedCleared by a regulator
Stage is inferred from the highest trial phase in the indexed corpus and 1 registered trial. It describes the research record, not a recommendation.
Mass and formula from PubChem CID 87815447. No verified residue count for this compound.
| Study | Type | Year | Summary depth |
|---|---|---|---|
| Recent advances in dermal fibroblast senescence and skin aging: unraveling mechanisms and pioneering therapeutic strategies. TakeawayThe review highlights the role of fibroblast senescence in skin aging and explores emerging therapeutic strategies, though empirical validation is needed. | review | 2025 | Full text read0.80 |
| Seizure-related death exhibits a circadian rhythm independent of seizure timing or sleep in a mouse model of Dravet syndrome. FindingNot reported in abstract. | Animal | 2025 | Full text read0.80 |
| Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. TakeawayThis review highlights the importance of POT and LAT transporters in the cellular transport of ultrashort peptides, but lacks specific data to support clinical applications. | review | 2022 | Full text read0.70 |
| Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides. FindingTERT gene expression increased eightfold in 'stationary' aging cultures. | In vitro | 2020 | Full text read0.80 |
What people are saying
anecdotal · not evidenceUnverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Cartalax (AED peptide) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.